首页 / 院系成果 / 成果详情页

The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma  期刊论文  

  • 编号:
    3FB43FD2C89F03835F30FA04F303EF80
  • 作者:
    Liu, Yao#*[1,2,3]Han, Jia[1,3];Shioya, Akihiro[1,3];Zhang, YangXian(张阳现)[1,3,4]Dung, Vu Anh[1,3,5];Oyama, Takeru[1,3];Guo, Xin[1,3,6];Yang, Qian[7,8];Ito, Tohru[9,10];Yamada, Sohsuke[1,3];
  • 语种:
    英文
  • 期刊:
    DIAGNOSTIC PATHOLOGY ISSN:1746-1596 2025 年 20 卷 1 期 ; JAN 8
  • 收录:
  • 关键词:
  • 摘要:

    BackgroundHepatoblastoma (HB) is the most common malignant solid tumor of the liver in children and is a fatal disease with a poor prognosis. Therefore, indicators that can be used for the early prediction of the HB prognosis are necessary. Sodium glucose cotransporter 2 (SGLT2) is a glucose transporter protein present in the proximal renal tubules. Studies have shown that SGLT2 is associated with the occurrence of tumors and is upregulated in various tumors. Peroxiredoxin 4 (PRDX4) is an antioxidant enzyme with a secretory function and is located in the cytoplasmic endoplasmic reticulum. Recent reports have suggested that it is closely related to the development and prognosis of various cancers. To some degree, this is highly suggestive of the interplay between SGLT2 and PRDX4.MethodsIn the present study, clinical data and post-surgical paraffin-embedded specimens from 75 HB patients were collected, and hematoxylin and eosin and immunohistochemical staining of SGLT2 and PRDX4 were used to analyze their expression and correlation with the clinicopathological features and prognosis.ResultsWe found that low SGLT2 and high PRDX4 expression predicted a significantly shorter survival and worse clinical condition in HB patients. Furthermore, when low SGLT2 expression was combined with high PRDX4 expression, the event-free survival and overall survival were significantly reduced. Univariate and multivariate Cox proportional hazards analyses showed that low SGLT2 and high PRDX4 expression in HB were independent prognostic factors for the survival after surgical resection.ConclusionThe immunohistochemical combination of low SGLT2 and high PRDX4 expression can independently predict a poor prognosis in HB patients.

  • 推荐引用方式
    GB/T 7714:
    Liu Yao,Han Jia,Shioya Akihiro, et al. The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma [J].DIAGNOSTIC PATHOLOGY,2025,20(1).
  • APA:
    Liu Yao,Han Jia,Shioya Akihiro,Zhang Yang-Xian,&Yamada Sohsuke.(2025).The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma .DIAGNOSTIC PATHOLOGY,20(1).
  • MLA:
    Liu Yao, et al. "The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma" .DIAGNOSTIC PATHOLOGY 20,1(2025).
  • 入库时间:
    1/15/2025 9:31:32 AM
  • 更新时间:
    1/15/2025 9:31:32 AM
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:2 下载次数:0
浏览次数:2
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部